These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 7685472
1. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. Ali SF, Newport GD, Scallet AC, Binienda Z, Ferguson SA, Bailey JR, Paule MG, Slikker W. Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472 [Abstract] [Full Text] [Related]
2. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR. Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631 [Abstract] [Full Text] [Related]
3. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Frederick DL, Ali SF, Slikker W, Gillam MP, Allen RR, Paule MG. Neurotoxicol Teratol; 1995 Jul; 17(5):531-43. PubMed ID: 8551999 [Abstract] [Full Text] [Related]
4. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. Ricaurte GA, Martello AL, Katz JL, Martello MB. J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470 [Abstract] [Full Text] [Related]
5. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB. J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824 [Abstract] [Full Text] [Related]
6. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Colado MI, Green AR. Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800 [Abstract] [Full Text] [Related]
7. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Kleven MS, Woolverton WL, Seiden LS. Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850 [Abstract] [Full Text] [Related]
8. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Battaglia G, Yeh SY, De Souza EB. Pharmacol Biochem Behav; 1988 Feb 29; 29(2):269-74. PubMed ID: 2452449 [Abstract] [Full Text] [Related]
9. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue. Johnson MP, Huang XM, Nichols DE. Pharmacol Biochem Behav; 1991 Dec 29; 40(4):915-22. PubMed ID: 1726189 [Abstract] [Full Text] [Related]
10. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW. JAMA; 1988 Jul 01; 260(1):51-5. PubMed ID: 2454332 [Abstract] [Full Text] [Related]
11. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. Schmidt CJ, Wu L, Lovenberg W. Eur J Pharmacol; 1986 May 13; 124(1-2):175-8. PubMed ID: 2424776 [Abstract] [Full Text] [Related]
12. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI, Murray TK, Green AR. Br J Pharmacol; 1993 Mar 13; 108(3):583-9. PubMed ID: 7682129 [Abstract] [Full Text] [Related]
13. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X, Baumann MH, Xu H, Rothman RB. Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556 [Abstract] [Full Text] [Related]
14. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat. Johnson M, Hanson GR, Gibb JW. Biochem Pharmacol; 1987 Dec 01; 36(23):4085-93. PubMed ID: 2446629 [Abstract] [Full Text] [Related]
15. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Esteban B, O'Shea E, Camarero J, Sanchez V, Green AR, Colado MI. Psychopharmacology (Berl); 2001 Mar 01; 154(3):251-60. PubMed ID: 11351932 [Abstract] [Full Text] [Related]
16. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Gough B, Ali SF, Slikker W, Holson RR. Pharmacol Biochem Behav; 1991 Jul 01; 39(3):619-23. PubMed ID: 1723797 [Abstract] [Full Text] [Related]
17. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R, Kerans A, O'Neill B, Harkin A. Neuropharmacology; 2006 Jan 01; 50(1):69-80. PubMed ID: 16188283 [Abstract] [Full Text] [Related]
18. Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat. Cox BM, Shah MM, Cichon T, Tancer ME, Galloway MP, Thomas DM, Perrine SA. Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():229-35. PubMed ID: 24121061 [Abstract] [Full Text] [Related]
19. Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain. Meyer JS, Ali SF. Ann N Y Acad Sci; 2002 Jun 03; 965():373-80. PubMed ID: 12105113 [Abstract] [Full Text] [Related]
20. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates. Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW. Brain Res; 1988 Dec 06; 474(2):359-63. PubMed ID: 2463059 [Abstract] [Full Text] [Related] Page: [Next] [New Search]